Estimation of drug excretion rate from blood into the gut using a three-compartment closed model

Pharmacological Research

Volumn 37, Issue 2, 1998, Pages 157-163

  Wu, Guang ^a,b  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Compartmental model; Drug excretion rate; Gut; Monte Carlo simulation; Sensitivity analysis

Indexed keywords

ARTICLE; CALCULATION; COMPARTMENT MODEL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG TISSUE LEVEL; DRUG TRANSPORT; INTESTINE; PRIORITY JOURNAL; SIMULATION;

EID: 0032005930     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0279     Document Type: Article

References (26)

1. 1. Gabrielsson J, Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. Stockholm: Swedish Pharmaceutical Press, 1994: pp. 399-404.
2. 2. Faulds D, Goa KL, Benfield P. Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drug 1993; 45: 953-1040.
3. 3. Henricesson S, Lindholm A, Johansson A. Identification of a sulfate conjugate of cyclosporine. Transplant Proc 1989; 21: 837-8.
4. 4. Carson ER, Cobelli C, Finkelstein L. The Mathematical Modeling of Metabolic and Endocrine System: Model Formulation, Identification, and Validation. New York: John Wiley & Sons, 1983: pp. 12-22.
5. 5. Notari RE. Biopharmaceutics and Clinical Pharmacokinetics: An Introduction. 4th edn. New York: Marcel Dekker, 1987.
6. 6. PCNONLIN: Software for the Statistical Analysis on Nonlinear Models on Micros. Version 4.0. North Carolina: Scientific Consulting, Inc., 1992.
7. 7. P-Pharm: Pharmacokinetic Data Modeling Software. Version 1.2. Créteil: Simed S.A., 1994.
8. 8. Abbottbase: Pharmacokinetic Systems. Abbott Park, IL: Abbott Laboratories, 1991.
9. 9. WinNonlin. Standard Edition, Version 1.1, Model-3 and 4. North Carolina: Scientific Consulting, Inc., 1996.
10. 10. Wu G, Cossettini P, Furlanut M. Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by one-, two and three-compartment models using Bayesian and nonlinear least squares methods. Pharmacol Res 1996; 34: 47-57.
11. 11. Ptachcinski RJ, Venkataramanan R, Burckart GJ, Gray JA, Van Thiel DH, Sanghvi A, Rosenthal JT. Cyclosporine kinetics in healthy volunteers. Clin Pharmacol 1987; 27: 24-38.
12. 12. Gardier AM, Methé D, Guédeney X, Barré J, Benvenutti C, Navarro N, Vernillet L, Loisance D, Cachera J-P, Jacotot B, Tillement J-P. Effects of plasma lipid level on blood distribution and pharmacokinetics of cyclosporin A. Ther Drug Monit 1993; 15: 274-80.
13. 13. Kovarik JM, Vernillet L, Mueller EA, Freiburghaus R, Niederberger W, Kutz K. Cyclosporine disposition and metabolite profiles in renal transplant patients receiving a microemulsion formulation. Ther Drug Monit 1994; 16: 519-25.
14. 14. Follath F, Wenk M, Vozeh S, Thiel G, Brunner F, Loertscher B, Lemaire M, Nussbaumer K, Niederberger W, Wood A. Intravenous cyclosporine kinetics in renal failure. Clin Pharmacol Ther 1983; 34: 638-43.
15. 15. Karlsson MO, Lindberg-Freijs A. Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses. J Pharmacokinet Biopharm 1990; 18: 293-311.
16. 16. Bréant V, Charpiat B, Sab JM, Maire P, Jelliffe RW. How many patients and blood levels are necessary for population pharmacokinetic analysis? A study of a one compartment model applied to cyclosporine. Eur J Clin Pharmacol 1996; 51: 283-9.
17. 17. Anderson JE, Munday AS, Kelman AW, Whiting B, Briggs JD, Knepil J, Thomson AH. Evaluation of a Bayesian approach to the pharmacokinetic interpretation of cyclosporin concentrations in renal allograft recipients. Ther Drug Monit 1994; 16: 160-5.
18. 18. Hammersley JM, Handscomb DC. Monte Carlo Methods. Monographs on Statistics and Applied Probability. London: Chapman and Hall, 1983.
19. 19. Jelliffe RW, Schumitzky A, Van Guilder M. Non-pharmacokinetic clinical factors affecting aminoglycoside therapeutic precision: a simulation study. Drug Invest 1992; 4: 20-9.
20. 20. SigmaPlot: Scientific Graphing Software for Windows. Version 2.0. Erkrath: Jandel Scientific GmbH, 1994.
21. 21. Jacoby SLS, Kowalik JS, Burner HB. Mathematical Modeling with Computers. New Jersey: Prentice-Hall, Inc., 1980: pp. 23-37.
22. 22. Richardson GP, Pugh AL III. Introduction to System Dynamics Modeling with Dynamo. Massachusetts: MIT Press, pp. 277-93.
23. 23. Jørgensen SE. Fundamentals of Ecological Modelling: Developments in Environmental Modelling 19. 2nd edn. Amsterdam: Elsevier, 1994: pp. 23-60.
24. 24. Carson ER, Cobelli C, Finkelstein L. The Mathematical Modeling of Metabolic and Endocrine System: Model Formulation, Identification, and Validation. New York: John Wiley & Sons, 1983: pp. 227-9.
25. 25. Janssen PHM. Assessing sensitivities and uncertainties in models: a critical evaluation. In: Grasman J, van Straten G, eds. Predictability and Nonlinear Modelling in Natural Sciences and Economics. London: Kluwer Academic Publishers, 1994: pp. 344-61.
26. 26. Kleijnen JPC. Sensitivity analysis versus uncertainty analysis: when to use what? In: Grasman J, van Straten G, eds. Predictability and Nonlinear Modelling in Natural Sciences and Economics. London: Kluwer Academic Publishers, 1994: pp. 322-33.